Crossmark

A comparative effectiveness trial for universal psychosocial screening with the Psychosocial Assessment Tool (PAT) across 18 childhood cancer programs in the United States: adoption, penetration, and health equity

Crossref DOI link: https://doi.org/10.1186/s13012-026-01493-4

Published Online: 2026-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barakat, Lamia P. https://orcid.org/0000-0002-0938-4712
Scialla, Michele A.

Ramaswamy, Nithyasri

Deatrick, Janet A.

Arasteh, Kamyar

Sandler, Eric

Hammer, Shannon N.

Kazak, Anne E.
Funding

Funding for this research was provided by:

American Cancer Society (RSG-19-115)
License Information

Text and Data Mining valid from 2026-02-26

Version of Record valid from 2026-04-07
More Information

Article History

Received: 3 March 2025

Accepted: 16 February 2026

First Online: 26 February 2026

Declarations

:

: The Central IRB at the Children’s Hospital of Philadelphia served as the IRB of record (19–017117).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below